Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Neurology Pubmed

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Download PDF

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Tabrizi, Sarah J; Reilmann, Ralf; Roos, Raymund A C; Durr, Alexandra; Leavitt, Blair; Owen, Gail; Jones, Rebecca; Johnson, Hans; Craufurd, David; Hicks, Stephen L; Kennard, Christopher; Landwehrmeyer, Bernhard; Stout, Julie C; Borowsky, Beth; Scahill, Rachael I; Frost, Chris; Langbehn, Douglas R; ,
The Lancet Neurology , Volume 11 (1): 12 – Feb 9, 2012

Loading next page...
 
/lp/pubmed/potential-endpoints-for-clinical-trials-in-premanifest-and-early-wyVkR26pyY

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2012 Elsevier Ltd. All rights reserved.
ISSN
1474-4422
eISSN
1474-4465
DOI
10.1016/S1474-4422(11)70263-0
pmid
22137354

Abstract

Journal

The Lancet Neurology – Pubmed

Published: Feb 9, 2012

There are no references for this article.